|
PDHX expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.64985860715706E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.14620002378274E-09 |
| Normal-vs-Stage2 |
5.405800E-02 |
| Normal-vs-Stage3 |
1.064220E-01 |
| Normal-vs-Stage4 |
7.184000E-03 |
| Stage1-vs-Stage2 |
4.548200E-01 |
| Stage1-vs-Stage3 |
1.232630E-01 |
| Stage1-vs-Stage4 |
8.099000E-01 |
| Stage2-vs-Stage3 |
6.459600E-01 |
| Stage2-vs-Stage4 |
4.940200E-01 |
| Stage3-vs-Stage4 |
2.750000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.91091628368667E-12 |
| Normal-vs-AfricanAmerican |
2.582700E-03 |
| Normal-vs-Asian |
2.583000E-01 |
| Caucasian-vs-AfricanAmerican |
3.313000E-01 |
| Caucasian-vs-Asian |
6.852800E-01 |
| AfricanAmerican-vs-Asian |
9.907600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.34412530789541E-13 |
| Normal-vs-Female |
1.058580E-03 |
| Male-vs-Female |
4.960300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.592600E-04 |
| Normal-vs-Extreme_Weight |
5.25929966244121E-10 |
| Normal-vs-Obese |
2.85639999986209E-07 |
| Normal-vs-Extreme_Obese |
8.041000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.036200E-01 |
| Normal_Weight-vs-Obese |
8.296000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.948830E-01 |
| Extreme_Weight-vs-Obese |
6.532200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.772440E-01 |
| Obese-vs-Extreme_Obese |
2.093800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.652200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.14179998789155E-09 |
| Normal-vs-Age(61-80Yrs) |
9.04099994869512E-09 |
| Normal-vs-Age(81-100Yrs) |
5.99980000000055E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.622300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.742300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.757500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.667200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.659700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.687900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.66955338443131E-12 |
| Normal-VS-Type2 PRCC |
6.47670000000211E-05 |
| Normal-VS-KIRP CIMP |
1.897040E-01 |
| Normal-VS-Unclassified PRCC |
5.213900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.265400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.03029999999993E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.727800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.464600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.480800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.076300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.34450000002884E-06 |
| Normal-vs-N1 |
2.940000E-01 |
| Normal-vs-N2 |
4.113700E-02 |
| N0-vs-N1 |
4.275800E-02 |
| N0-vs-N2 |
2.769600E-01 |
| N1-vs-N2 |
7.064000E-02 |
|
|
